| Dr Michal Maranto Phillips, MD | |
|
1 Mercy Way Ste 20, Bella Vista, AR 72714-3000 | |
| (479) 802-5555 | |
| (479) 876-2829 |
| Full Name | Dr Michal Maranto Phillips |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 1 Mercy Way Ste 20, Bella Vista, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659497311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M4446 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
Nanion Technologies GmbH, a supplier of automated, parallel patch-clamp systems based in Munich, Germany, has announced that they would appeal the decision of the European Patent Office (EPO) to uphold the disputed Molecular Devices patent EP 1,040,349.
Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder. The symposium begins at Georgia Tech's Institute for Bioengineering and Bioscience on November 4 and concludes the evening of November 5.
In this interview, Jolanta Vidugiriene, a Senior Research Scientist at Promega Corporation, talks to News-Medical about tools for studying metabolism in NAFLD/NASH research.
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.
› Verified 1 days ago
| Entity Name | Mercy Health Northwest Arkansas Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265490916 PECOS PAC ID: 0648177873 Enrollment ID: O20031216000788 |
News Archive
Nanion Technologies GmbH, a supplier of automated, parallel patch-clamp systems based in Munich, Germany, has announced that they would appeal the decision of the European Patent Office (EPO) to uphold the disputed Molecular Devices patent EP 1,040,349.
Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder. The symposium begins at Georgia Tech's Institute for Bioengineering and Bioscience on November 4 and concludes the evening of November 5.
In this interview, Jolanta Vidugiriene, a Senior Research Scientist at Promega Corporation, talks to News-Medical about tools for studying metabolism in NAFLD/NASH research.
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michal Maranto Phillips, MD 1 Mercy Way Ste 20, Bella Vista, AR 72714-3000 Ph: (479) 802-5555 | Dr Michal Maranto Phillips, MD 1 Mercy Way Ste 20, Bella Vista, AR 72714-3000 Ph: (479) 802-5555 |
News Archive
Nanion Technologies GmbH, a supplier of automated, parallel patch-clamp systems based in Munich, Germany, has announced that they would appeal the decision of the European Patent Office (EPO) to uphold the disputed Molecular Devices patent EP 1,040,349.
Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder. The symposium begins at Georgia Tech's Institute for Bioengineering and Bioscience on November 4 and concludes the evening of November 5.
In this interview, Jolanta Vidugiriene, a Senior Research Scientist at Promega Corporation, talks to News-Medical about tools for studying metabolism in NAFLD/NASH research.
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.
› Verified 1 days ago
Dr. Carroll Eugene Holsted, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3 Woodbridge Dr, Bella Vista, AR 72714 Phone: 479-855-2160 Fax: 479-876-6312 | |
Angela Mae Dozier, APRN-FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Saxilby Ln, Bella Vista, AR 72715 Phone: 702-908-7027 | |
Haley Elizabeth Vo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 24 Sugar Creek Ctr, Bella Vista, AR 72714 Phone: 479-876-1414 Fax: 479-855-4540 | |
Dr. Mark S. Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mercy Way, Bella Vista, AR 72714 Phone: 479-802-5555 Fax: 479-876-2829 |